Clinical Trials Browser

Phase 1 × Primary Myelofibrosis × mivebresib × Clear all

NCT04480086 2023-08-29

Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

Phase 1 Terminated

Neoplasms, Primary Myelofibrosis